The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Date of Patent:
Apr. 16, 2024

Filed:

Jul. 12, 2019
Applicant:

Immatics Biotechnologies Gmbh, Tuebingen, DE;

Inventors:

Hans Georg Rammensee, Tuebingen, DE;

Stefan Stevanovic, Tuebingen, DE;

Cecile Gouttefangeas, Tuebingen, DE;

Toni Weinschenk, Aichwald, DE;

Peter Lewandrowski, Tuebingen-Hirschau, DE;

Attorney:
Primary Examiner:
Assistant Examiner:
Int. Cl.
CPC ...
A61K 39/00 (2006.01); A61K 38/10 (2006.01); C07K 7/08 (2006.01); C07K 14/47 (2006.01); C07K 14/705 (2006.01); C07K 16/18 (2006.01); C07H 21/00 (2006.01); C12N 5/0783 (2010.01); C12N 5/09 (2010.01); C12N 15/10 (2006.01); C12N 15/86 (2006.01);
U.S. Cl.
CPC ...
A61K 38/10 (2013.01); A61K 39/00115 (2018.08); C07K 7/08 (2013.01); C07K 14/4747 (2013.01); C07K 14/4748 (2013.01); C07K 14/7056 (2013.01); C07K 16/18 (2013.01); C07H 21/00 (2013.01); C12N 15/10 (2013.01); C12N 15/86 (2013.01);
Abstract

The present invention relates to peptides, nucleic acids, and cells for use in the immunotherapy of cancer. The present invention furthermore relates to survivin-derived tumor-associated cytotoxic T cell (CTL) peptide epitopes, alone or in combination with other tumor-associated peptides that serve as active pharmaceutical ingredients of vaccine compositions that stimulate anti-tumor immune responses. The present invention specifically relates to three novel peptide sequences and variants thereof derived from HLA class I and class II molecules of human tumor cells that can be used in vaccine compositions for eliciting anti-tumor immune responses.


Find Patent Forward Citations

Loading…